BRAF and brain neoplasm: Next generation sequencing (NGS) techniques, among others (e.g. Sanger sequencing, immunohistochemistry, fluorescence in situ hybridization—FISH) led to a better understanding of brain tumors at the molecular level and resulted in the identification of promising actionable targets—such as BRAF-V600E mutations—revealing novel opportunities for targeted treatment.